| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 17 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 2 | TACROLIMUS | 17 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 4 | TACROLIMUS OINTMENT 0.1% | 17 |
| 5 | DEXAMETHASONE | 15 |
| 6 | DEXAMETHASONE 1.5 MG | 15 |
| 7 | PREDNISOLONE | 13 |
| 8 | PREDNISOLONE ORAL | 13 |
| 9 | PREDNISOLONE ORAL SOLUTION | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REMDESIVIR | 9 | 0.0007 |
| 1 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| 2 | GANCICLOVIR SODIUM | 4 | 0.0004 |
| 3 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 6 | BASILIXIMAB | 3 | 0.0003 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 8 | ISATUXIMAB | 1 | 0.0002 |
| 9 | VALGANCICLOVIR | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 9 | 0.0007 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 7 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 4 | 0.0000 |